A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/14/2006	US7135173 Antiviral activity of Shiga toxin
11/14/2006	US7135171 Endothelial precursor cells for enhancing and restoring vascular function
11/14/2006	US7135170 Methods for treating viral infection using IL-28 and IL-29
11/14/2006	CA2399842C Microfabricated devices for the storage and selective exposure of chemicals and devices
11/14/2006	CA2367124C A thrombin blood fraction for use in a medical procedure
11/14/2006	CA2343099C Role of human kis (hkis) as an inhibitory kinase of the cyclin-dependentkinase inhibitor p27. compositions, methods and uses thereof to control cell proliferation
11/14/2006	CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006	CA2139571C Interferon receptor binding peptides
11/14/2006	CA2040410C Wound healing compositions containing il-1 and a growth factor
11/12/2006	CA2606334A1 Methods of using phhla2 to co-stimulate t-cells
11/09/2006	WO2006119406A2 Compositions and methods for increasing osteoblast cell differentiation and bone generation
11/09/2006	WO2006119355A2 Mammalian hypothalamic nutrient modulation of glucose metabolism
11/09/2006	WO2006119121A2 Cell-surface decoration with active agents
11/09/2006	WO2006119071A2 Methods and uses of leukotriene b4 hydroxylases to treat diseases
11/09/2006	WO2006119062A2 Sclerostin epitopes
11/09/2006	WO2006119061A2 Hcv ns3 protease inhibitors
11/09/2006	WO2006119035A2 Vegf variants
11/09/2006	WO2006119013A2 Nogo receptor functional motifs and peptide mimetics related thereto and methods of using the same
11/09/2006	WO2006118871A2 Antiestrogenic glyceollins suppress human breast and ovarian carcinoma proliferation and tumorigenesis
11/09/2006	WO2006118805A2 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
11/09/2006	WO2006118719A2 Method of improving learning and memory in mammals
11/09/2006	WO2006118701A1 Method of increasing the salivary sialic acid content in a mammal
11/09/2006	WO2006118617A2 EXPRESSING TGF-β PROTEINS IN PLANT PLASTIDS
11/09/2006	WO2006118459A1 Antiviral peptides
11/09/2006	WO2006118364A1 COSMETIC COMPOSITION CONTAINING (20S)-GINSENOSIDE Rg3 FOR PREVENTING AND IMPROVING SKIN WRINKLES
11/09/2006	WO2006118331A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus
11/09/2006	WO2006118313A1 Novel polypeptide and use thereof
11/09/2006	WO2006118246A1 Transdermal absorption accelerator
11/09/2006	WO2006118196A1 Dpp4 inhibitor and pharmaceutical application thereof
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006117995A1 Therapeutic agent for loss of scalp hair
11/09/2006	WO2006117805A1 Antiviral peptide against hepatitis c virus
11/09/2006	WO2006117784A2 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
11/09/2006	WO2006117573A1 Combination therapy
11/09/2006	WO2006117565A2 Glucagon-like-peptide-2 (glp-2) analogues
11/09/2006	WO2006117241A2 Polypeptide, vaccine and use thereof
11/09/2006	WO2006117011A1 Dye conjugates of template-fixed peptidomimetics
11/09/2006	WO2006116949A1 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis
11/09/2006	WO2006116948A1 Interleukin-6 polyethylene glycol conjugate and its preparing method and use
11/09/2006	WO2006116873A1 Diagnosis and treatment of endometriosis
11/09/2006	WO2006116867A1 Genemap of the human genes associated with crohn's disease
11/09/2006	WO2006116808A1 Treating peripheral neuropathies
11/09/2006	WO2006100021A8 Use of the mst protein for the treatment of a thromboembolic disorder
11/09/2006	WO2006094704A3 Natural ligand of g protein coupled receptor rcc356 and uses thereof
11/09/2006	WO2006084141A8 Suspension formulation of interferon
11/09/2006	WO2006083947A3 Compositions and methods for treating fibrotic disorders
11/09/2006	WO2006074051A3 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RESTORING β-CELL MASS AND FUNCTION
11/09/2006	WO2006053159A3 Medical device for delivering biologically active material
11/09/2006	WO2005124342A3 Methods and means for treatment of osteoarthritis
11/09/2006	WO2005112639A3 Treatment or prevention of respiratory viral infections with immunomodulator compounds
11/09/2006	WO2005094200A3 Biomarkers for differentiating between type 2 and type 2 diabetes
11/09/2006	WO2005089429A3 Sfec, a sperm flagellar energy carrier protein
11/09/2006	WO2005055948A3 Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
11/09/2006	WO2004094454A3 Hla-a2 tumor associated antigen peptides and compositions
11/09/2006	WO2003016479A3 Excitatory glycine receptors and methods
11/09/2006	WO1998035042A8 Activity dependent neurotrophic factor iii (adnf iii)
11/09/2006	US20060253915 Transgenic Mice Containing Kir3.3 Potassium Channel Gene Disruptions
11/09/2006	US20060253914 Ha4,a new osteoblast-and chondrocyte-specific small secreted peptide, compositions and methods of use
11/09/2006	US20060253912 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/09/2006	US20060252958 Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril
11/09/2006	US20060252921 Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens
11/09/2006	US20060252919 Vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis
11/09/2006	US20060252916 Modified glucagon-like peptide-1 analogs
11/09/2006	US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006	US20060252724 Method and composition for modulating bone growth
11/09/2006	US20060252718 Sphingolipids polyalkylamine conjugates for use in transfection
11/09/2006	US20060252717 Sphingoid polyalkylamine conjugates for vaccination
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252701 Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV)-like activity for the treatment of neurological and neuropsychological disorders
11/09/2006	US20060252700 Immunomodulator
11/09/2006	US20060252699 Administering dipeptides consisting of isoleucine, leucine, valine, or glycine and combinations thereof; tripeptides consisting of isoleucine, leucine, valine, or glycine and combinations thereof; alpha-ketobutyrate; propionyl A CoA, and combinations thereof
11/09/2006	US20060252698 Compounds for inhibiting cathepsin activity
11/09/2006	US20060252697 Compounds that bind to growth hormone receptor
11/09/2006	US20060252696 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
11/09/2006	US20060252695 Analysis and separation of platelet-derived growth factor proteins
11/09/2006	US20060252694 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/09/2006	US20060252693 Glucagon-like peptide-1 analogs
11/09/2006	US20060252692 Inhibitors for use in hemostasis
11/09/2006	US20060252691 Topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration of a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/09/2006	US20060252690 Factor VII or VIIa - Like Molecules
11/09/2006	US20060252689 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060252688 Therapeutic uses of BPI protein products in BPI-deficient humans
11/09/2006	US20060252687 Modulating stroma-cell-derived-factor (SDF-1) receptor activity in hematopoietic stem cells, hematopoietic progenitor cells, primitive granulocytes, primitive erythroid cells, leukocytes, and neutrophils; reducing ability to act as substrate to amino/carboxypeptidases
11/09/2006	US20060252686 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
11/09/2006	US20060252685 Treatment for sleep apnea
11/09/2006	US20060252684 Osteopontin-based cancer therapies
11/09/2006	US20060252683 Preparation of a peptide compound (SYRAPRO-2000) and its use for the activation of protein phosphatase-2A1 enzyme
11/09/2006	US20060252682 Liquid growth hormone formulation and process of preparation thereof
11/09/2006	US20060252681 Pain relief agents
11/09/2006	US20060252680 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
11/09/2006	US20060252679 Preventive and/or trerapeutic drgs for itch
11/09/2006	US20060252678 Lowering circulating free fatty acid levels, reducing body mass, maintaining weight loss, and treating obesity-related diseases and disorders
11/09/2006	US20060252677 Postsynaptic proteins
11/09/2006	US20060252676 Analgesic antitumor peptide from scorpion and method of producing it
11/09/2006	US20060252675 Use of selected cyclosporins for the treatment of hepatitis C infection
11/09/2006	US20060252674 Methods for pretreating a subject with extracorporeal photopheresis
11/09/2006	US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
11/09/2006	US20060252672 Protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-gylosylation-increasing methods, and engineered hosts expressing products with increased N-glycosylation
11/09/2006	US20060252671 Forming iron nitrosyl hemoglobin
11/09/2006	US20060252670 Method of reducing drug-induced adverse side effects in a patient

1 ... 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 ... 3163